BD-CHINA Global Pharma Collaboration Forum to Be Held in San Francisco During J.P. Morgan Healthcare Conference
VCBeat
Internet Medical Health Media
The globally renowned J.P. Morgan Healthcare Conference will be held in mid-January in San Francisco, USA. Tens of thousands of decision-makers from leading pharmaceutical companies, innovative drug developers, and investment institutions around the world will converge to discuss cutting-edge trends and negotiate international collaborations.On January 15, 2025, the BD-CHINA Global Pharmaceutical Cooperation Forum, initiated by the BD-CHINA Pharmaceutical Club and co-hosted by VCBeatTo be held in San Francisco, this event will bring together global pharmaceutical executives focused on partnerships in the Chinese market, US-dollar investment firms, innovative biopharma leaders, and cross-border service providers. It aims to create a dedicated platform for showcasing and exchanging ideas on China’s pharmaceutical innovations during the JPM Conference season. Industry colleagues are cordially invited to register and participate!
*This is an invitation-only event; please scan the QR code to complete registration.
The JPM Main Forum will be held from January 13 to 15, spanning three days. The VCBeat China Global Pharmaceutical Cooperation Forum has strategically avoided the peak attendance period by scheduling its session for the afternoon of the third day. Located just across the street from the main forum venue, it offers attendees a more convenient and relaxed opportunity to participate amidst their busy schedules, while also providing an ideal setting to summarize and exchange insights from the entire event.
The forum features afternoon general sessions and an evening networking reception, combining industry insights with business networking to facilitate both formal and informal exchanges.
If you are a regular attendee of JPM, you are welcome to join this forum to reconnect with old friends and meet new faces. If it is your first time participating, this platform will help you familiarize yourself with the industry discourse and find partners as you embark on the path of global business development (BD) collaborations.
With just one month remaining until the conference, it is imperative for both individuals and companies to finalize their air travel plans. For assistance with ticketing, transit, EVUS enrollment, and related matters, please add the assistant of [United Business Travel], a supporting organization of this forum (see end of article), for one-on-one support.
If you have any questions, please contact us:
VCBeat New Medicine | Capillaries:
17782369627 (WeChat ID same)
BD-CHINA Pharma Club was co-founded by multiple industry veterans. Grounded in Business Development (BD), it provides a platform for learning, exchange, practical experience sharing, and business connectivity, catering to stakeholders ranging from multinational pharmaceutical companies and large domestic pharma enterprises to innovative biopharma firms, as well as professionals from Chairmen and CEOs to BD Managers. The club is dedicated to creating broader networking scenarios for business development collaboration in China’s pharmaceutical industry, empowering pharmaceutical companies to drive performance growth and promoting diversified industry development. The club’s offerings include: - **BD-Linked**: WeChat communities, verified contact directories, overseas communities, and CEO communities; - **BD-CHINA Closed-Door CEO Salons**; - **BD-CHINA Casual Networking Dinners**; - **BD-CHINA Cooperation Social Parties**; - **BD-CHINA Pharma Cooperation Summit**; - **BD-Evolve (BD-CHINA Excellence Center)**: Customized growth plans for professionals from CEOs to BD Managers; - **BD-Talent (BD-CHINA Talent Center)**: Efficient candidate sourcing and background screening services for employers.
VB New Medicine is a media and research platform under VCBeat, dedicated to the biopharmaceutical sector. It provides innovators and entrepreneurs with communication value characterized by “depth” and “incremental growth” through two dimensions: content and operations. In terms of content, it primarily features exclusive financing announcements, corporate interviews, thematic track analyses, in-depth industry interpretations, and sector reports. On the operational front, it focuses on practical challenges and discusses industrial trends through branded initiatives such as “Park Tours” and “VB Thought Sharing Sessions,” fostering actual collaborations through intellectual exchange.
Thematic Achievements:【CGT】【IPO - Financial Report Analysis】【iPSC】【Nuclear Medicine Drugs】【Protein Degraders】【Upstream Tools】【Synthetic Biology】【Organoids and Organs-on-a-Chip】【VB Insight Salon] etc.
Meilian Business Travel has been established for 10 years, providing exceptional air ticketing services to B2B enterprises and individual consumers. With partnerships spanning over 2,000 airports and route coverage across more than 160 countries and regions, it holds a distinct competitive advantage in Sino-U.S. business travel. Services include:
Clear Service Process: Customers provide travel requirements — At least four flight options are provided — Customers select the most cost-effective option — Refund, change, and endorsement rules, as well as potential travel risks, are explained — Customers make a final decision after full understanding — Ticket issuance — Pre-departure reminders to ensure all boarding documents are ready — Smooth departure and after-sales service.
One-sentence summary: Appropriate airfare, clear refund and change policies, one-on-one human communication and travel consultation (always reaching a real person, not a bot), andand emergency handling of other unforeseen circumstances, ensuring you a worry-free and comfortable travel experience.
For inquiries, please scan the QR code below:
Recommended Concurrent Events
Click to Register for the Delegation and Participate in Other JPM Week Events
